EMA — authorised 12 November 2021
- Marketing authorisation holder: ROCHE REGISTRATION GMBH
- Status: approved
🇪🇺 IMDEVIMAB in European Union
EMA authorised IMDEVIMAB on 12 November 2021
Marketing authorisation
IMDEVIMAB in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in European Union
Frequently asked questions
Is IMDEVIMAB approved in European Union?
Yes. EMA authorised it on 12 November 2021.
Who is the marketing authorisation holder for IMDEVIMAB in European Union?
ROCHE REGISTRATION GMBH holds the EU marketing authorisation.